mRNA Vaccine Targeting Epstein-Barr Virus (EBV) in Healthy Young Adults
mRNA Vaccine Targeting Epstein-Barr Virus (EBV) in Healthy Young Adults
Not yet recruiting · NCT07557602 · Registry updated 2026-04-29Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| mRNA Vaccine Targeting Epstein-Barr Virus (EBV) in Healthy Young Adults | DNA Virus Infections, Epstein-Barr virus infection, Herpesviridae infectious disease, Infections, Tumor Virus Infections, viral infectious disease | Not yet recruiting | Phase 1 | 2026-04-29 | NCT07557602 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Vaccine Company, Inc, a wholly owned subsidiary of Eli Lilly and Company | 1 |
2 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Nucleus Network Pty Ltd | Melbourne | Australia | 10 |
| Q-Pharm Pty Ltd/Nucleus Network Pty Ltd | Herston | Australia | 1 |